Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin D. Mullen

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|March 18, 2004
Interplay of portal pressure, portal perfusion and hepatic arterial inflow in modulating expression of hepatic encephalopathy in patients with spontaneous or artificially created portosystemic shuntsKevin D Mullen
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|March 18, 2004
Newer aspects of hepatic encephalopathyKevin D Mullen
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 11, 2014
Reply: To PMID 24365449Kevin D Mullen
Metabolic Brain Disease|October 18, 2016
Introduction: current state of knowledge of hepatic encephalopathyKevin D Mullen
Hepatology (Baltimore, Md.)|February 5, 2002
Treatment of hepatorenal syndrome: lessons from the MARS trialKevin D Mullen
Gastroenterology & Hepatology|September 10, 2010
The Treatment of Patients With Hepatic Encephalopathy: Review of the Latest Data from EASL 2010Kevin D Mullen
Nature Reviews. Gastroenterology & Hepatology|August 13, 2010
Mechanisms, diagnosis and management of hepatic encephalopathyRavi Prakash, Kevin D Mullen
Minerva Gastroenterologica E Dietologica|October 21, 2016
Optimal treatment of hepatic encephalopathySanath Allampati, Kevin D Mullen
Metabolic Brain Disease|November 24, 2004
MARS--does it stand the test of time?Kevin D Mullen, Srinivasan Dasarathy
Hepatology (Baltimore, Md.)|October 22, 2003
New mechanism of selective killing of activated hepatic stellate cellsMilan Dodig, Kevin D Mullen
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|March 18, 2004
Interplay of portal pressure, portal perfusion and hepatic arterial inflow in modulating expression of hepatic encephalopathy in patients with spontaneous or artificially created portosystemic shuntsKevin D Mullen
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|March 18, 2004
Newer aspects of hepatic encephalopathyKevin D Mullen
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 11, 2014
Reply: To PMID 24365449Kevin D Mullen
Metabolic Brain Disease|October 18, 2016
Introduction: current state of knowledge of hepatic encephalopathyKevin D Mullen
Hepatology (Baltimore, Md.)|February 5, 2002
Treatment of hepatorenal syndrome: lessons from the MARS trialKevin D Mullen
Gastroenterology & Hepatology|September 10, 2010
The Treatment of Patients With Hepatic Encephalopathy: Review of the Latest Data from EASL 2010Kevin D Mullen
Nature Reviews. Gastroenterology & Hepatology|August 13, 2010
Mechanisms, diagnosis and management of hepatic encephalopathyRavi Prakash, Kevin D Mullen
Minerva Gastroenterologica E Dietologica|October 21, 2016
Optimal treatment of hepatic encephalopathySanath Allampati, Kevin D Mullen
Metabolic Brain Disease|November 24, 2004
MARS--does it stand the test of time?Kevin D Mullen, Srinivasan Dasarathy
Hepatology (Baltimore, Md.)|October 22, 2003
New mechanism of selective killing of activated hepatic stellate cellsMilan Dodig, Kevin D Mullen
Pageof 8